• Lanore D
  • SPECanin 2005
  • Novembre 2005
  • : Cancérologie
  • : Chien, chat
  • : Bibliographie

1- Bateman SW, Mathews KA, Abrams-Ogg AC et coll . Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit. J. Am. Vet. Med. Assoc. 1999;215(6):798-804.
2-Chun R, Feline and canine hemangiosarcomas. Compend. Cont. Educ. Vet. Pract. 1999;21(7):622-629.
3- Johnson KA, Powers BE, Withrow SJ et coll. Splenectomy in dogs : predictors of neoplasia and survival after splenectomy. J. Vet. Intern. Med. 1989;3:160-166.
4- Hammer AS, Couto CG, Flippi J et coll. Efficacy and toxicity of VAC chemitherapy (vincristin, doxorubicin and cyclophosphamide) in dogs with hemangiosarcoma. J. Vet. Intern. Med. 1991;5:160-166.
5- Knapp DW, Aronsohn MG, Harpster NK. Cardiac arythmias associated with mass lesions of the canine spleen. J. Am. Anim. Hosp. Assoc. 1993;29:122-128.
6- Magonl JP, Marchal T, Delisle F et coll. Les tumeurs de la rate, dans :Cancérologie clinique du chien - éditions à compte d'auteur -Lezay- 1998:177-181.
7- Ogilvie GK, Moore AS. Chemotherapy: Properties, use and patient management. In: Managing the veterinary cancer patient. Veterinary learning systems Co. Trenton. 1995: 64-86.
8- Ogilvie GK, Powers BE, Mallinckrodt CH et coll. Surgery and doxorubicin in dogs with hemangiosarcoma. J. Vet. Intern. Med. 1996;10:379-384.
9- O'Keefe DA, Couto CG. Fine-needle aspiration of the spleen as an aid in the diagnosis of splénomegalt. J. Vet. Int.Med. 1987;1(3):102-109.
10- Patnaïk AK, Liu SK. Angiosarcoma in cats. J. Small Anim. Pract. 1977;18:191-198.
11-Raffe M, O'Toole E. Arythmia in critical care. In: The veterinary Icu Book. Wingfield WE et Raffe MR. Teton New Media -Jackson hole. Wyoming. 2002.
12- Ramirez S, Douglass JP, Robertson ID. Ultrasonographic features of canine abdominal malignant histiocytosis. Vet. Radiol. Ultrasound 2002;43(2):167-170.
13- Scaveli TD, Patnaik AK, Mehlaff CJ et coll. Hemangiosarcoma in the cat: retrospective evaluation of 31 surgical cases. J. Am. Vet. Med. Assoc; 1985;187:817-819.
14- Sorenmo KU, Jeglum KA, Helfand SC. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J. Vet. Int. Med. 1993;7:370-376.
15- Sorenmo KU, Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J. Vet. Int. Med. 2000;14:395-398.
16- Sorenmo KU, Baez JL, Clifford CA et coll. Efficacy and toxicity of a dose-intensified doxorubicin protocole in canine hemangiosarcoma. J. Vet. Int. Med. 2004;18(2):209-213.
17- Sprangler WL, Culbertson MR, Kass PH. Primary mesenchymal (nonangiomatous/nonlymphomatous) neoplasms occuring in the canine spleen : anatomic classification, immunohistochemistry and mitotic activity correlated with patient survival. Vet. Pathol. 1991;31:34-47.
18- Sprangler WL, Kass PH. Pathologic and prognostic characteristics of splenomegaly in dogs due to fibrohistiocytic nodules : 98 cases. Vet. Pathol. 1998;35:488-498.
19- Vail DM Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomised multi-institutional clinical trial. Clin. Cancer Res. 1995;1:1165-1170.
20- Waters DJ, Hayden DW, Walter PA. Intracranial lesions in dogs with hemangiosarcoma. J. Vet. Int. Med. 1989;3:222-230.
21- Weinstein MJ, Carpenter JL, Schunck CJM. Non angiogenic and non lymphomatous sarcomas of the canine spleen : 57 cases (1975-1987). J. Am. Vet. Med. Assoc.1989;195:784-788.
22- Wood CA, Moore AS et coll. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone : 32 cases (1991-1993). J. Am. Anim. Hosp. Assoc. 1998;34:417-421

a - Skorupski KA, Clifford CA, Paoloni MC. CCNU for the treatment of dogs with metastatic or disseminated histiocytic sarcoma. 23nd Annual Conference of the Veterinary Cancer Society, Madison, 2003, p36

Pour en savoir plus
- Couturier L. Intérêt de l'imagerie dans l'histiocytose maligne du chien. Point Vet. 2003;34(241):74-79.
- Maliver P, Lagadic M. Les désordres et tumeurs histiocytaires du chien. Point Vet. 2003;34(241):18-23.

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...